Trial intelligence / Profile preview

Effect of ondansetron and ginger on postoperative nausea, vomiting, shivering, and headache in cesarean section

IRCT20220614055172N1Phase 3Completed

Sponsor
Hamadan University of Medical Sciences
Start
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ondansetron and ginger in None, sponsored by Hamadan University of Medical Sciences. Primary endpoints: Nausea and vomiting incidence and/or severity, Shivering incidence and/or severity and 1 more. Started Aug 2022; status: completed.

02

Drugs

ondansetronginger

Beyond the preview

Go deeper on IRCT20220614055172N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220614055172N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call